Improving medication compliance and adherence in patients suffering from osteoporosis
Osteoporosis Treatment (compliance/adherence in women’s health)
Osteoporosis medications are generally prescribed to elderly female patients with an average age of 74 years1
- Tablet medications must be taken:
- first thing in the morning on an empty stomach,
- with 200mls of water,
- patient staying upright for 30 minutes,
- cannot be crushed or taken with food or drinks
- Swallowing difficulty common among elderly people
This means patient compliance is a major problem - 50-60% of patients discontinue treatment within one year.2
Meeting the unmet need
A solution to compliance/adherence problems in the treatment of osteoporosis.
A novel, patented orange flavoured drinkable oral solution presented as 100ml single use, once weekly treatment
Bonasol® is a patient-friendly, senior-friendly formulation.
The formulation provides important compliance-enhancing and clinical features. The dosage form has been optimised for a drug with very low bioavailability by formulating as an oral solution which facilitates more rapid access.3
The gold-standard medicine for the treatment of osteoporosis in patient-friendly, senior-friendly presentation is a unique product – there is no other non-tablet, non-injectable bisphosphonate product approved or marketed in Europe.
- Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink J. Morley & A. Moayyeri & L. Ali & A. Taylor & M. Feudjo-Tepie & L. Hamilton & J. Bayly. Osteoporosis International (2020) 31:533–545. Click here to download.
- The Adherence Gap Report –why osteoporosis patients don’t continue with treatment. International Osteoporosis Foundation. Click here to download.
- SmPC for Bonasol Once Weekly 70mg Oral Solution (IE). www.hpra.ie